Guerbet Achieves Regulatory Milestone for Lipiodol® in Vascular Embolization
Guerbet announces a significant regulatory milestone for Lipiodol® Ultra Fluid, receiving a positive outcome for its new indication in vascular embolization procedures. This development allows for improved visualization during interventional radiology in combination with cyanoacrylate-based surgical glues. The achievement is seen as a validation of years of clinical practice and enhances the safety and precision of embolization techniques across Europe.
VILLEPINTE, France, April 24, 2026 /PRNewswire/ — GUERBET (FR0000032526 GBT): Guerbet, a global leader in medical imaging, announces a positive outcome from a worksharing procedure, involving several EU member states, for a new Lipiodol® indication in interventional radiology procedures…